OUR CLINICAL TRIALS

  • Reset


A phase 3, multicenter, randomized, open-label, active-controlled study of trastuzumab deruxtecan (T-DXd) versus trastuzumab emtansine Leer mas
DOLAF- An international multicenter phase II trial of Durvalumab (MEDI4736) plus OLAparib plus Fulvestrant in Leer mas
European cooperative study of primary systemic therapy in women with operable breast cancer and T Leer mas
ELacestrant In Preoperative SEtting, a window of opportunity study Leer mas
A randomised phase III trial of adjuvant radiation therapy versus observation following breast conserving surgery Leer mas
A phase II randomized, double-blind, study of ipatasertib (GDC-0068), an Akt inhibitor, in combination with Leer mas
Translational Study Of Tumor Samples From DS8201- A-U301 and DS8201-A-U302 Trials Leer mas
Phase 2 Randomized, Double-Blinded, Controlled Study of Tucatinib vs. Placebo in Combination with Capecitabine and Leer mas
A randomized, three-arm, multicenter comparison of 1 year and 2 years of Herceptin® versus no Leer mas

COLLABORATE